deltatrials
Completed PHASE3 NCT00137787

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases

Sponsor: Bayer

Conditions Febrile Neutropenia
Interventions cefepime ciprofloxacin
Updated 6 times since 2017 Last updated: Jun 25, 2018 Started: Apr 30, 2005 Primary completion: Dec 31, 2009 Completion: May 31, 2010

This PHASE3 trial investigates Febrile Neutropenia and is currently completed. Bayer leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jul 2018 — Jan 2021 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  5. Jun 2018 — Jul 2018 [monthly]

    Unknown Status PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
  • Center for Supporting Hematology-Oncology Trials
Data source: Center for Supporting Hematology-Oncology Trials

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Nagoya, Japan